Affiliation:
1. Departments of Medicine and Microbiology, Royal Victoria Hospital and McGill University, Faculty of Medicine, Montreal, Quebec, H3A 2B4 Canada
Abstract
Netilmicin (Sch 20569), a semisynthetic aminoglycoside antibiotic, was compared with gentamicin, tobramycin, and amikacin against 242 clinical isolates of
Pseudomonas
and
Enterobacteriaceae
. The minimum inhibitory concentration (MIC) was determined in both solid and liquid media. Netilmicin exhibited typical aminoglycoside properties, such as little effect of inoculum size on MIC, relatively small gap between MIC and minimum bactericidal concentration, and potentiation of anti-
Pseudomonas
activity in the presence of carbenicillin. Netilmicin provided no advantage in antimicrobial activity over gentamicin for either
Pseudomonas
or
Enterobacteriaceae
. Nearly complete cross-resistance to netilmicin was encountered with isolates resistant to gentamicin in either solid or liquid media. Netilmicin was less active than gentamicin against isolates of
Pseudomonas
and
Providencia
. Major discrepancies between MIC values determined in agar as opposed to those determined in broth were encountered for most isolates of
Pseudomonas
but also, depending upon antibiotic tested, for between 15 and 40% of isolates of
Enterobacteriaceae
. This new aminoglycoside agent will be useful clinically only if it is shown to be significantly less toxic than presently available analogues.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献